P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846656.55700.df |
| _version_ | 1797287917428670464 |
|---|---|
| author | R. M. Rifkin C. L. Costello R. E. Birhiray S. Kambhampati J. Richter R. Abonour H. C. Lee Y. J. Kim K. Ren D. M. Stull D. Cherepanov K. Bogard S. J. Noga S. Girnius |
| author_facet | R. M. Rifkin C. L. Costello R. E. Birhiray S. Kambhampati J. Richter R. Abonour H. C. Lee Y. J. Kim K. Ren D. M. Stull D. Cherepanov K. Bogard S. J. Noga S. Girnius |
| author_sort | R. M. Rifkin |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:46Z |
| format | Article |
| id | doaj.art-9c6ec397c04a494c8ea253eea32a2a4c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:46Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-9c6ec397c04a494c8ea253eea32a2a4c2024-03-02T03:51:55ZengWileyHemaSphere2572-92412022-06-01683783810.1097/01.HS9.0000846656.55700.df202206003-00837P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)R. M. Rifkin0C. L. Costello1R. E. Birhiray2S. Kambhampati3J. Richter4R. Abonour5H. C. Lee6Y. J. Kim7K. Ren8D. M. Stull9D. Cherepanov10K. Bogard11S. J. Noga12S. Girnius131 Rocky Mountain Cancer Centers/US Oncology Research, Denver2 Moores Cancer Center, University of California San Diego, La Jolla3 Hematology Oncology of Indiana/American Oncology Network, Indianapolis4 Kansas City Veterans Affairs Medical Center, Kansas City5 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York6 Indiana University School of Medicine, Indianapolis7 MD Anderson Cancer Center, Houston, United States of America8 Data Analytics, Evidera, St-Laurent, Canada9 Takeda Development Center Americas, Inc. (TDCA)10 Takeda Pharmaceuticals U.S.A., Inc., Lexington9 Takeda Development Center Americas, Inc. (TDCA)10 Takeda Pharmaceuticals U.S.A., Inc., Lexington9 Takeda Development Center Americas, Inc. (TDCA)11 TriHealth Cancer Institute, Cincinnati, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000846656.55700.df |
| spellingShingle | R. M. Rifkin C. L. Costello R. E. Birhiray S. Kambhampati J. Richter R. Abonour H. C. Lee Y. J. Kim K. Ren D. M. Stull D. Cherepanov K. Bogard S. J. Noga S. Girnius P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) HemaSphere |
| title | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_full | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_fullStr | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_full_unstemmed | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_short | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_sort | p947 comparative effectiveness of oral ixazomib lenalidomide dexamethasone ird after initial bortezomib v based induction vs parenteral v based therapy in newly diagnosed multiple myeloma ndmm |
| url | http://journals.lww.com/10.1097/01.HS9.0000846656.55700.df |
| work_keys_str_mv | AT rmrifkin p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT clcostello p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT rebirhiray p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT skambhampati p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT jrichter p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT rabonour p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT hclee p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT yjkim p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT kren p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT dmstull p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT dcherepanov p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT kbogard p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT sjnoga p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT sgirnius p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm |